SecBot SecBot

ELV

Elevance Health, Inc.
NYSE· Hospital & Medical Service Plans· Inc. IN· CIK 0001156039 Traditional Finance
$444.41 +14.72 (+3.43%)
Nov 16 4:00 PM ET · prev $429.69
Market cap
$92.9B
Large cap
Consensus
Buy
68% Buy or better · 28 analysts
Median target
$492.00
+11% · range $406.00–523.00
1 year
+34.3%
from $330.91 · Nov 17
30 days
+3.8%
from $428.26
52-week range
$280.74–445.28
−0% from high · low Mar 9
Avg volume 20D
1.36M
shares / day
Short interest
4.54M
≈2.1% of shares · −11.5%
Days to cover
3.3
at average volume
Insider net
−$4.7M
3 buyers · 6 sellers · since Mar 2
New fund stakes
8
Q2 2026 13F · 6 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read BULLISH 10 reports · 90 days
Balance 0 bearish · 2 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 9/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders bought $2.2M at an average $332.76. 6 insiders sold $7.0M. Price is 34% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 87 added (8 new), 43 trimmed or exited. Largest new: Diamond Hill Capital Management, (Investment Advisor) $96.6M, Sound Shore Management /Ct/ $94.2M.

  • AnalystsBULLISH

    19 of 28 rate it Buy or better. Median target $492.00 (+11%).

  • Short sellersSTEADY

    Short interest −11.5% to 4.54M shares. 3.3 days to cover, ≈2.1% of shares.

  • TrendUPTREND

    7% above its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q2 2026
8
new positions
6
exits
$278.8M
in new stakes · top 4 shown
FundMoveSharesValue
NORGES BANKADD3,958,856$1.5B
FMR LLCADD3,131,652$1.2B
CITIGROUP INCDOUBLED2,096,863$810.9M
GOLDMAN SACHS GROUP INCADD2,005,613$775.6M
BANK OF AMERICA CORP /DE/TRIM1,806,267$698.5M
AmundiTRIM1,644,537$636.0M
MANUFACTURERS LIFE INSURANCE COMPANY, THETRIM1,528,416$591.1M
CITADEL ADVISORS LLCTRIM906,386$350.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

28 analysts
Buy 68% rate it Buy or better
Strong Buy7Buy12Hold9Sell0Strong Sell0
12-month targets · 21 analysts

Price is inside the target range. Median implies +11%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 27, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Oct 23, 2026TD Cowen
MAINTAIN
MAINTAINBuy
Oct 22, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 22, 2026Guggenheim
MAINTAIN
MAINTAINBuy
Oct 22, 2026Morgan Stanley
MAINTAIN
MAINTAINEqual-Weight
Oct 22, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Congressional trades
ELV trades disclosed by members of Congress, with disclosure delay.
2 members · 2 buys / 1 sells
DateMemberType AmountDisclosed
Jul 20, 2026 Ro KhannaDHouse Spouse account · Elevance Health Inc SELL $1K–$15K Aug 7, 2026 +18d
May 15, 2026 Ro KhannaDHouse Spouse account · Elevance Health Inc BUY $1K–$15K Jun 9, 2026 +25d
Dec 29, 2025 Markwayne MullinRSenate Joint account · Elevance Health Inc BUY $15K–$50K Jan 16, 2026 +18d

Insider ledger

Form 4
$2.2M
bought · 3 insiders
$7.0M
sold · 6 insiders
+33.6%
vs their $332.76 cost
DateInsiderTypeValue
Nov 5, 2026
LAVU RATNAKAR
EVP & Chief Digital Info Ofr
Nov 5, 2026
SELL$572.0K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$173.6K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$139.7K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$724.1K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$244.8K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$105.2K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$509.5K
Oct 22, 2026
Kaye Mark
EVP & CFO
Oct 22, 2026
SELL$757.6K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 0 in posts · 1 in comments
Recent comments
All social signals and their track records

Short side

FINRA· Oct 30, 2026
4,544,947
shares short
-11.5%
vs prior settlement
3.3
days to cover
≈2.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 10, 2026 SEC
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during investor meetings. The company expects…
8-K · Impact 2/10
Nov 5, 2026 SEC
Elevance Health officer Lavu Ratnakar filed a Form 144 notice of intent to sell 1,300 shares of common stock, with an…
144 · Impact 2/10
Nov 5, 2026 Insider
LAVU RATNAKAR sold 1,300 shares
EVP & Chief Digital Info Ofr @ $440.00 ($572.0K)
Oct 28, 2026 SEC
Elevance Health filed an automatic shelf registration (S-3ASR) to register an unlimited amount of senior and…
S-3ASR · Impact 3/10
Oct 22, 2026 Insider
Kaye Mark sold 400 shares
EVP & CFO @ $434.00 ($173.6K)
Oct 22, 2026 Insider
Kaye Mark sold 321 shares
EVP & CFO @ $435.25 ($139.7K)
Oct 21, 2026 Earnings result
ELV Q3 2026 Earnings: EPS $6.99 (+47.8% vs est)
Aug 20, 2026 Event
WIEGMAN v. ELEVANCE HEALTH, INC.
Court ruling (insd), Docket: 1:24-cv-01930
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 21, 2026
Earnings result
ELV Q3 2026 Earnings: EPS $6.99 (+47.8% vs est)
Aug 20, 2026
Enforcement
WIEGMAN v. ELEVANCE HEALTH, INC.
Court ruling (insd), Docket: 1:24-cv-01930
Aug 17, 2026
Enforcement
Imagine 360 Administrators, LLC v. Elevance Health, Inc.
Court ruling (cand), Docket: 5:26-cv-08365
Jul 23, 2026
Gov. contract
$75M govt contract mod: WELLPOINT FEDERAL SOLUTIONS, INC.
Agency: Department of Health and Human Services. Mod P00095: A/B MAC J6
Jul 15, 2026
Earnings date
ELV Q2 2026 Earnings Before Market Open, 2026-07-15

Washington

Corporate Lobbying

59 lobbying filings and 12 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

19 filings · 2 bullish · 1 bearish · 1 mixed · 15 neutral
All ELV filing & press-release reports (19)